| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 04/12/2007 | WO2007039583A1 Liposomal vaccine compositions comprising a polysaccharide antigen and a protein adjuvant |
| 04/12/2007 | WO2007039552A1 Interleukin-1 conjugates and uses thereof |
| 04/12/2007 | WO2007039458A2 Hiv peptide conjugates and uses thereof |
| 04/12/2007 | WO2007039451A1 Use of the neutrophil activating protein of helicobacter pylori (hp-nap) and/or of its portions as adjuvants for the development of t helper type 1 (th1) immune responses |
| 04/12/2007 | WO2007039256A2 Binding domains of proteins of the repulsive guidance molecule (rgm) protein family and functional fragments thereof, and their use |
| 04/12/2007 | WO2007039192A2 Compositions and methods for treating tumors presenting survivin antigens |
| 04/12/2007 | WO2007039151A1 Blockers of transforming growth factor beta and its receptors for the treatment of infectious diseases |
| 04/12/2007 | WO2007039150A2 Cell populations having immunoregulatory activity, method for isolation and uses |
| 04/12/2007 | WO2007039070A2 Polynucleotides of haemophilus parasuis and its use |
| 04/12/2007 | WO2007038926A1 Solid vaccine formulation |
| 04/12/2007 | WO2007038862A1 Nucleic acid immunological composition for human metapneumovirus |
| 04/12/2007 | WO2007016715A3 Immune response inducing preparations |
| 04/12/2007 | WO2007016240A3 Use of antibody to m-csf |
| 04/12/2007 | WO2007014772A3 Direct and indirect effector cell protease receptor-1 (epr-1) inhibitors as antiplatelet agents |
| 04/12/2007 | WO2007014335A3 Combinations comprising gemcitabine and tyrosine kinase inhibitors for the treatment of pancreatic cancer |
| 04/12/2007 | WO2007011993B1 Lawsonia vaccine and methods of use thereof |
| 04/12/2007 | WO2007009469A3 Potency assays for antibody drug substance binding to an fc receptor |
| 04/12/2007 | WO2007003421A3 Humanised antibodies specific for nogo-a and pharmaceutical uses thereof |
| 04/12/2007 | WO2006138004A3 Immunogenic compositions for chlamydia trachomatis |
| 04/12/2007 | WO2006133911A3 Hepatitis c virus nucleic acid vaccine |
| 04/12/2007 | WO2006133408A9 Breast cancer and prostate cancer assessment |
| 04/12/2007 | WO2006126029A3 Malaria vaccines |
| 04/12/2007 | WO2006125921A3 Antibody or antibody fragment coupled with an immunogenic agent |
| 04/12/2007 | WO2006124932A3 Kinase peptides and antibodies |
| 04/12/2007 | WO2006124641A3 Anti-mesothelin antibodies useful for immunological assays |
| 04/12/2007 | WO2006121869A3 Compositions and methods for treating mood and anxiety disorders |
| 04/12/2007 | WO2006113601A3 Leptospirosis culture process |
| 04/12/2007 | WO2006107924A3 Ehrlichia canis diva (differentiate infected from vaccinated animals) |
| 04/12/2007 | WO2006102901A3 Immunogenic egfr peptides comprising foreign t cell stimulating epitope |
| 04/12/2007 | WO2006089209A3 Txr1 and enhanced taxane sensitivity based on the modulation of a pathway mediated thereby |
| 04/12/2007 | WO2006074430A3 Biomarkers for melanoma |
| 04/12/2007 | WO2005107796A3 Cellular permissivity factor for viruses, and uses thereof |
| 04/12/2007 | WO2005089447A3 Streptococcus agalactiae vaccine |
| 04/12/2007 | WO2004071408A3 Aβ BINDING MOLECULES |
| 04/12/2007 | WO2004024874A8 Antibodies that recognize hyperproliferative cells and methods of making and using same |
| 04/12/2007 | WO2004013287A3 Antibodies against c3a receptor |
| 04/12/2007 | US20070082866 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 04/12/2007 | US20070082865 Compositions and methods for treatment of airway hypersecretion |
| 04/12/2007 | US20070082863 Methods and compositions for maturing dendritic cells utilizing inosine-containing compounds |
| 04/12/2007 | US20070082860 Hla-a24-restricted cancer antigen peptides |
| 04/12/2007 | US20070082846 Nucleotide and protein sequences of vertebrate delta genes and methods based thereon |
| 04/12/2007 | US20070082840 Combination therapy for inhibition of platelet aggregation |
| 04/12/2007 | US20070082391 Modified CEA Nucleic Acid and Expression Vectors |
| 04/12/2007 | US20070082382 Development of human monoclonal antibodies and uses thereof |
| 04/12/2007 | US20070082369 Method for production and use of mite group 1 proteins |
| 04/12/2007 | US20070082361 DNA and proteins or peptides specific of bacteria of the Neisseria meningitidis species, methods for obtaining them and biological applications thereof |
| 04/12/2007 | US20070082335 Methods and compositions for treatment of viral infections based on tsg101-vps28 interaction |
| 04/12/2007 | US20070082043 Liposomal vaccine |
| 04/12/2007 | US20070082015 Cloning and expression of outer membrane protein C of Salmonella typhi Ty2 and conjugation of the purified insoluble protein to VI-polysaccharide for use as a vaccine for typhoid fever |
| 04/12/2007 | US20070082014 Injectable vaccines against multiple meningococcal serogroups |
| 04/12/2007 | US20070082013 Use of botulinum toxin for producing drug for preventing or treating final phase of lung troubles |
| 04/12/2007 | US20070082012 Administering a vaccine containing an attenuated or killed influenza virus, canine parainfluenza, canine distemper virus, canine parvovirus, and canine adenovirus-2 |
| 04/12/2007 | US20070082011 Recombinant proteins from filoviruses and their use |
| 04/12/2007 | US20070082010 Urogenital or anorectal transmucosal vaccine delivery system |
| 04/12/2007 | US20070082009 Methods of preparation of live attenuated bacterial vaccine by alteration of dna adenine methylase (dam) activity in those bacteria |
| 04/12/2007 | US20070082007 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 04/12/2007 | US20070082006 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 04/12/2007 | US20070082005 Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics |
| 04/12/2007 | US20070082004 Method for removing a proteinaceous component from a liquid-phase surfactant preparation |
| 04/12/2007 | US20070082003 Method for selecting and producing vaccine components and vaccines based thereon |
| 04/12/2007 | US20070082002 Neutralizing High Affinity Human Monoclonal Antibodies Specific to RSV F-Protein and Methods for their Manufacture and Therapeutic use thereof |
| 04/12/2007 | US20070082001 Novel engineered superantigen for human therapy |
| 04/12/2007 | US20070082000 administering to the mammal with at a site of neoangiogenesis, a pharmaceutical preparation comprising a polypeptide containing a truncated extracellular D1-1 polypeptide |
| 04/12/2007 | US20070081999 Antithrombotic von willebrand factor (vwf) collagen bridging blockers |
| 04/12/2007 | US20070081998 A beta -derived diffusible ligands (ADDL) specific immunoglobulin for use in prevention and treatment of alzheimer's diseases |
| 04/12/2007 | US20070081997 Diagnostics and therapeutics for diseases associated with kallikrein 9 (klk9) |
| 04/12/2007 | US20070081996 Method of treating depression using a TNFalpha antibody |
| 04/12/2007 | US20070081995 Methods and compositions for targeting IFNAR2 |
| 04/12/2007 | US20070081994 Chimeric Heteromultimer Adhesins |
| 04/12/2007 | US20070081993 Pharmaceutical composition comprising a bispecific antibody for epcam |
| 04/12/2007 | US20070081992 Fusion proteins for blood-brain barrier delivery |
| 04/12/2007 | US20070081991 Compositions and methods for modulation of immune responses |
| 04/12/2007 | US20070081990 Regulation of expression of high-affinity immunoglobulin e (ige) receptor beta-chain |
| 04/12/2007 | US20070081989 Treatment of B cell diseases using anti-germline antibody binding agents |
| 04/12/2007 | US20070081977 Device for transdermal administration of active substances |
| 04/12/2007 | US20070081974 Antibody targeting osteoclast-associated protein |
| 04/12/2007 | US20070081973 Cytokine polypeptides |
| 04/12/2007 | US20070081972 Polymer-based delivery system for immunotherapy of cancer |
| 04/12/2007 | US20070081960 With collagen and a polysaccharide such as hydroxyethyl starch as stabilizer; reduced toxicity and/or a reduced immunogenicity |
| 04/12/2007 | US20070081942 Gene differentially expressed in breast and bladder cancer, and encoded polypeptides |
| 04/12/2007 | DE10392933B4 Use of CD152, PD-1 (progressive cell death-1) or BTLA (B and T lymphocyte attenuator), particularly CD152-positive cells, for treatment, prevention and diagnosis of autoimmune diseases and inflammation |
| 04/12/2007 | CA2624730A1 Compositions and methods for treating inflammation |
| 04/12/2007 | CA2624562A1 Binding domains of proteins of the repulsive guidance molecule (rgm) protein family and functional fragments thereof, and their use |
| 04/12/2007 | CA2624503A1 Solid vaccine formulation |
| 04/12/2007 | CA2624486A1 Novel sea lice vaccine |
| 04/12/2007 | CA2624291A1 Nucleic acid immunological composition for human metapneumovirus |
| 04/12/2007 | CA2624269A1 Exemestane compounds, compositions and related uses thereof |
| 04/12/2007 | CA2623693A1 Methods for reducing blood pressure |
| 04/12/2007 | CA2623497A1 Compositions and methods for treating tumors presenting survivin antigens |
| 04/12/2007 | CA2623353A1 Cell populations having immunoregulatory activity, method for isolation and uses |
| 04/12/2007 | CA2623287A1 Interleukin-1 conjugates and uses thereof |
| 04/12/2007 | CA2622772A1 Immunomodulatory compositions and uses therefor |
| 04/12/2007 | CA2622635A1 Polynucleotides of haemophilus parasuis and its use |
| 04/12/2007 | CA2621371A1 Human monoclonal antibodies to activin receptor-like kinase-1 |
| 04/12/2007 | CA2605781A1 Antigen binding molecules having modified fc regions and altered binding to fc receptors |
| 04/11/2007 | EP1772518A2 Mammalian-type glycosylation in plants |
| 04/11/2007 | EP1772517A2 DSP-3 dual specificity phosphatase |
| 04/11/2007 | EP1772152A2 Composition for inducing immunotolerance |
| 04/11/2007 | EP1771571A2 Recombinant aav based vaccine methods |
| 04/11/2007 | EP1771557A2 Gdf3 propeptides and related methods |